Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease

Sleep Medicine Reviews

Volumn 31, Issue , 2017, Pages 102-111

  Cedernaes, Jonathan ^a   Osorio, Ricardo S ^b   Varga, Andrew W ^b   Kam, Korey ^b   Schiöth, Helgi B ^a   Benedict, Christian ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Amyloid beta; Blood brain barrier; Circadian misalignment; Neurodegeneration; Orexin; Oxidative stress; Sleep disruption; Slow wave sleep; Tau

Indexed keywords

AMYLOID BETA PROTEIN; OREXIN A; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TAU PROTEIN;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN LEVEL; CIRCADIAN RHYTHM SLEEP DISORDER; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROENCEPHALOGRAM; HUMAN; METABOLITE; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATIVE STRESS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; RISK; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP WAKE DISRUPTION; AGING; ANIMAL; BRAIN; CIRCADIAN RHYTHM; DISEASE MODEL; METABOLISM; PATHOPHYSIOLOGY;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; HUMANS; SLEEP WAKE DISORDERS; TAU PROTEINS;

EID: 84961136218     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2016.02.002     Document Type: Review

References (111)

1. [1] Hardy, J.A., Higgins, G.A., Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992), 184–185.
2. Kang, J.E., Lim, M.M., Bateman, R.J., Lee, J.J., Smyth, L.P., Cirrito, J.R., et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326 (2009), 1005–1007.
3. Roh, J.H., Huang, Y., Bero, A.W., Kasten, T., Stewart, F.R., Bateman, R.J., et al. Disruption of the sleep-wake cycle and diurnal fluctuation of beta-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med, 4, 2012, 150ra22.
4. [4] Bateman, R.J., Wen, G., Morris, J.C., Holtzman, D.M., Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker. Neurology 68 (2007), 666–669.
5. [5] Bero, A.W., Yan, P., Roh, J.H., Cirrito, J.R., Stewart, F.R., Raichle, M.E., et al. Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat Neurosci 14 (2011), 750–756.
6. [6] Brody, D.L., Magnoni, S., Schwetye, K.E., Spinner, M.L., Esparza, T.J., Stocchetti, N., et al. Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321 (2008), 1221–1224.
7. [7] Horovitz, S.G., Braun, A.R., Carr, W.S., Picchioni, D., Balkin, T.J., Fukunaga, M., et al. Decoupling of the brain's default mode network during deep sleep. Proc Natl Acad Sci U S A 106 (2009), 11376–11381.
8. [8] Larson-Prior, L.J., Power, J.D., Vincent, J.L., Nolan, T.S., Coalson, R.S., Zempel, J., et al. Modulation of the brain's functional network architecture in the transition from wake to sleep. Prog Brain Res 193 (2011), 277–294.
9. [9] Spoormaker, V.I., Schroter, M.S., Gleiser, P.M., Andrade, K.C., Dresler, M., Wehrle, R., et al. Development of a large-scale functional brain network during human non-rapid eye movement sleep. J Neurosci Off J Soc Neurosci 30 (2010), 11379–11387.
10. [10] Samann, P.G., Wehrle, R., Hoehn, D., Spoormaker, V.I., Peters, H., Tully, C., et al. Development of the brain's default mode network from wakefulness to slow wave sleep. Cereb Cortex 21 (2011), 2082–2093.
11. [11] Wu, C.W., Liu, P.Y., Tsai, P.J., Wu, Y.C., Hung, C.S., Tsai, Y.C., et al. Variations in connectivity in the sensorimotor and default-mode networks during the first nocturnal sleep cycle. Brain Connect 2 (2012), 177–190.
12. [12] Bateman, R.J., Munsell, L.Y., Morris, J.C., Swarm, R., Yarasheski, K.E., Holtzman, D.M., Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med 12 (2006), 856–861.
13. [13] Huang, Y., Potter, R., Sigurdson, W., Kasten, T., Connors, R., Morris, J.C., et al. beta-amyloid dynamics in human plasma. Arch Neurol 69 (2012), 1591–1597.
14. [14] Kiyashchenko, LI, Mileykovskiy, BY, Maidment, N, Lam, HA, Wu, MF, John, J, et al. Release of hypocretin (orexin) during waking and sleep states. J Neurosci Off J Soc Neurosci 22 (2002), 5282–5286.
15. Roh, J.H., Finn, M.B., Stewart, F.R., Mahan, T.E., Cirrito, J.R., Heda, A., et al. Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease. J Exp Med 211 (2014), 2487–2496.
16. [16] Heier, M.S., Skinningsrud, A., Paus, E., Gautvik, K.M., Increased cerebrospinal fluid levels of nerve cell biomarkers in narcolepsy with cataplexy. Sleep Med 15 (2014), 614–618.
17. [17] Liguori, C., Romigi, A., Nuccetelli, M., Zannino, S., Sancesario, G., Martorana, A., et al. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurol 71 (2014), 1498–1505.
18. [18] Slats, D., Claassen, J.A., Lammers, G.J., Melis, R.J., Verbeek, M.M., Overeem, S., Association between hypocretin-1 and amyloid-beta42 cerebrospinal fluid levels in Alzheimer's disease and healthy controls. Curr Alzheimer Res 9 (2012), 1119–1125.
19. [19] Portelius, E., Soininen, H., Andreasson, U., Zetterberg, H., Persson, R., Karlsson, G., et al. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid. Neurodegener Dis 14 (2014), 98–106.
20. [20] Wennstrom, M., Londos, E., Minthon, L., Nielsen, H.M., Altered CSF orexin and alpha-synuclein levels in dementia patients. J Alzheimers Dis 29 (2012), 125–132.
21. [21] Dauvilliers, Y.A., Lehmann, S., Jaussent, I., Gabelle, A., Hypocretin and brain beta-amyloid peptide interactions in cognitive disorders and narcolepsy. Front Aging Neurosci, 6, 2014, 119.
22. [22] Schmidt, F.M., Kratzsch, J., Gertz, H.J., Tittmann, M., Jahn, I., Pietsch, U.C., et al. Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease. PloS One, 8, 2013 e63136.
23. [23] Fronczek, R., van Geest, S., Frolich, M., Overeem, S., Roelandse, F.W., Lammers, G.J., et al. Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol Aging 33 (2012), 1642–1650.
24. [24] Scammell, T.E., Narcolepsy. N. Engl J Med 373 (2015), 2654–2662.
25. [25] Liguori, C., Placidi, F., Albanese, M., Nuccetelli, M., Izzi, F., Marciani, M.G., et al. CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis?. J Sleep Res 23 (2014), 420–424.
26. [26] Kallweit, U., Hidalgo, H., Engel, A., Baumann, C.R., Bassetti, C.L., Dahmen, N., Post H1N1 vaccination narcolepsy-cataplexy with decreased CSF beta-amyloid. Sleep Med, 13, 2012, 323.
27. [27] Yamada, K., Holth, J.K., Liao, F., Stewart, F.R., Mahan, T.E., Jiang, H., et al. Neuronal activity regulates extracellular tau in vivo. J Exp Med 211 (2014), 387–393.
28. [28] Osorio, R.S., Pirraglia, E., Aguera-Ortiz, L.F., During, E.H., Sacks, H., Ayappa, I., et al. Greater risk of Alzheimer's disease in older adults with insomnia. J Am Geriatr Soc 59 (2011), 559–562.
29. [29] Benedict, C., Byberg, L., Cedernaes, J., Hogenkamp, P.S., Giedratis, V., Kilander, L., et al. Self-reported sleep disturbance is associated with Alzheimer's disease risk in men. Alzheimer's Dement J Alzheimer's Assoc 11 (2015), 1090–1097.
30. [30] Hahn, E.A., Wang, H.X., Andel, R., Fratiglioni, L., A change in sleep pattern may predict Alzheimer disease. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry 22 (2014), 1262–1271.
31. Lim, A.S., Yu, L., Kowgier, M., Schneider, J.A., Buchman, A.S., Bennett, D.A., Modification of the relationship of the apolipoprotein E epsilon4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol 70 (2013), 1544–1551.
32. [32] Tranah, G.J., Blackwell, T., Stone, K.L., Ancoli-Israel, S., Paudel, M.L., Ensrud, K.E., et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol 70 (2011), 722–732.
33. [33] Yaffe, K., Laffan, A.M., Harrison, S.L., Redline, S., Spira, A.P., Ensrud, K.E., et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 306 (2011), 613–619.
34. [34] Yaffe, K., Falvey, C.M., Hoang, T., Connections between sleep and cognition in older adults. Lancet Neurol 13 (2014), 1017–1028.
35. Ooms, S., Overeem, S., Besse, K., Rikkert, M.O., Verbeek, M., Claassen, J.A., Effect of 1 night of total sleep deprivation on cerebrospinal fluid beta-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol 71 (2014), 971–977.
36. [36] Di Meco, A., Joshi, Y.B., Pratico, D., Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles. Neurobiol Aging 35 (2014), 1813–1820.
37. Xie, L., Kang, H., Xu, Q., Chen, M.J., Liao, Y., Thiyagarajan, M., et al. Sleep drives metabolite clearance from the adult brain. Science 342 (2013), 373–377.
38. [38] D'Almeida, V, Lobo, LL, Hipólide, DC, de Oliveira, AC, Nobrega, JN, Tufik, S, Sleep deprivation induces brain region-specific decreases in glutathione levels. Neuroreport 9 (1998), 2853–2856.
39. [39] Mathangi, D.C.P., Shyamala, R., Subhashini, A.S., Effect of REM sleep deprivation on the antioxidant status in the brain of Wistar rats. Ann Neurosci 19 (2012), 161–164.
40. [40] Ramanathan, L., Gulyani, S., Nienhuis, R., Siegel, J.M., Sleep deprivation decreases superoxide dismutase activity in rat hippocampus and brainstem. Neuroreport 13 (2002), 1387–1390.
41. [41] Gomez-Gonzalez, B., Hurtado-Alvarado, G., Esqueda-Leon, E., Santana-Miranda, R., Rojas-Zamorano, J.A., Velazquez-Moctezuma, J., REM sleep loss and recovery regulates blood-brain barrier function. Curr Neurovasc Res 10 (2013), 197–207.
42. He, J., Hsuchou, H., He, Y., Kastin, A.J., Wang, Y., Pan, W., Sleep restriction impairs blood-brain barrier function. J Neurosci Off J Soc Neurosci 34 (2014), 14697–14706.
43. [43] Sultana, R., Butterfield, D.A., Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimers Dis 19 (2010), 341–353.
44. [44] Winkler, E.A., Sagare, A.P., Zlokovic, B.V., The pericyte: a forgotten cell type with important implications for Alzheimer's disease?. Brain Pathol 24 (2014), 371–386.
45. [45] Wu, Y.H., Swaab, D.F., Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Med 8 (2007), 623–636.
46. [46] Kondratova, A.A., Kondratov, R.V., The circadian clock and pathology of the ageing brain. Nat Rev Neurosci 13 (2012), 325–335.
47. [47] Wulff, K., Gatti, S., Wettstein, J.G., Foster, R.G., Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci 11 (2010), 589–599.
48. [48] Mander, B.A., Marks, S.M., Vogel, J.W., Rao, V., Lu, B., Saletin, J.M., et al. beta-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat Neurosci 18 (2015), 1051–1057.
49. [49] Menkes-Caspi, N., Yamin, H.G., Kellner, V., Spires-Jones, T.L., Cohen, D., Stern, E.A., Pathological tau disrupts ongoing network activity. Neuron 85 (2015), 959–966.
50. [50] Caselli, R.J., Dueck, A.C., Osborne, D., Sabbagh, M.N., Connor, D.J., Ahern, G.L., et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N. Engl J Med 361 (2009), 255–263.
51. [51] Jack, C.R. Jr., Knopman, D.S., Weigand, S.D., Wiste, H.J., Vemuri, P., Lowe, V., et al. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol 71 (2012), 765–775.
52. [52] Pan, W., Kastin, A.J., Can sleep apnea cause Alzheimer's disease?. Neurosci Biobehav Rev 47 (2014), 656–669.
53. [53] Lim, M.M., Gerstner, J.R., Holtzman, D.M., The sleep-wake cycle and Alzheimer's disease: what do we know?. Neurodegener Dis Manag 4 (2014), 351–362.
54. [54] Lucey, B.P., Bateman, R.J., Amyloid-beta diurnal pattern: possible role of sleep in Alzheimer's disease pathogenesis. Neurobiol Aging 35:Suppl. 2 (2014), S29–S34.
55. [55] Peter-Derex, L., Yammine, P., Bastuji, H., Croisile, B., Sleep and Alzheimer's disease. Sleep Med Rev 19 (2015), 29–38.
56. [56] Ju, Y.E., Lucey, B.P., Holtzman, D.M., Sleep and Alzheimer disease pathology–a bidirectional relationship. Nat Rev Neurol 10 (2014), 115–119.
57. [57] Huang, Y., Potter, R., Sigurdson, W., Santacruz, A., Shih, S., Ju, Y.E., et al. Effects of age and amyloid deposition on Abeta dynamics in the human central nervous system. Arch Neurol 69 (2012), 51–58.
58. [58] Saido, T., Leissring, M.A., Proteolytic degradation of amyloid beta-protein. Cold Spring Harb Perspect Med, 2, 2012 a006379.
59. [59] DeWitt, D.A., Perry, G., Cohen, M., Doller, C., Silver, J., Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp Neurol 149 (1998), 329–340.
60. [60] Bell, R.D., Zlokovic, B.V., Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118 (2009), 103–113.
61. [61] Rennels, M.L., Gregory, T.F., Blaumanis, O.R., Fujimoto, K., Grady, P.A., Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res 326 (1985), 47–63.
62. [62] Iliff, J.J., Wang, M., Liao, Y., Plogg, B.A., Peng, W., Gundersen, G.A., et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med, 4, 2012 147ra11.
63. [63] Bernardi, G., Cecchetti, L., Siclari, F., Buchmann, A., Yu, X., Handjaras, G., et al. Sleep reverts changes in human gray and white matter caused by wake-dependent training. Neuroimage 129 (2016), 367–377.
64. [64] Braak, H., Braak, E., Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82 (1991), 239–259.
65. [65] Iliff, J.J., Chen, M.J., Plog, B.A., Zeppenfeld, D.M., Soltero, M., Yang, L., et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci Off J Soc Neurosci 34 (2014), 16180–16193.
66. [66] Rothman, S.M., Herdener, N., Frankola, K.A., Mughal, M.R., Mattson, M.P., Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Abeta and pTau in a mouse model of Alzheimer's disease. Brain Res 1529 (2013), 200–208.
67. [67] Diekelmann, S., Born, J., The memory function of sleep. Nat Rev Neurosci 11 (2010), 114–126.
68. [68] Kress, B.T., Iliff, J.J., Xia, M., Wang, M., Wei, H.S., Zeppenfeld, D., et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 76 (2014), 845–861.
69. [69] Pratico, D., Uryu, K., Leight, S., Trojanoswki, J.Q., Lee, V.M., Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci Off J Soc Neurosci 21 (2001), 4183–4187.
70. [70] Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E.K., et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60 (2001), 759–767.
71. [71] Lin, M.T., Beal, M.F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006), 787–795.
72. Zhang, J., Zhu, Y., Zhan, G., Fenik, P., Panossian, L., Wang, M.M., et al. Extended wakefulness: compromised metabolics in and degeneration of locus ceruleus neurons. J Neurosci Off J Soc Neurosci 34 (2014), 4418–4431.
73. [73] Silva, R.H., Abilio, V.C., Takatsu, A.L., Kameda, S.R., Grassl, C., Chehin, A.B., et al. Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice. Neuropharmacology 46 (2004), 895–903.
74. [74] Gopalakrishnan, A., Ji, L.L., Cirelli, C., Sleep deprivation and cellular responses to oxidative stress. Sleep 27 (2004), 27–35.
75. [75] D'Almeida, V., Hipolide, D.C., Azzalis, L.A., Lobo, L.L., Junqueira, V.B., Tufik, S., Absence of oxidative stress following paradoxical sleep deprivation in rats. Neurosci Lett 235 (1997), 25–28.
76. Lim, A.S., Ellison, B.A., Wang, J.L., Yu, L., Schneider, J.A., Buchman, A.S., et al. Sleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer's disease. Brain J Neurol 137 (2014), 2847–2861.
77. [77] Gelber, R.P., Redline, S., Ross, G.W., Petrovitch, H., Sonnen, J.A., Zarow, C., et al. Associations of brain lesions at autopsy with polysomnography features before death. Neurology 84 (2015), 296–303.
78. [78] Singh, R., Kiloung, J., Singh, S., Sharma, D., Effect of paradoxical sleep deprivation on oxidative stress parameters in brain regions of adult and old rats. Biogerontology 9 (2008), 153–162.
79. [79] Someya, S, Yu, W, Hallows, WC, Xu, J, Vann, JM, Leeuwenburgh, C, et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143 (2010), 802–812.
80. [80] Minoshima, S., Giordani, B., Berent, S., Frey, K.A., Foster, N.L., Kuhl, D.E., Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 42 (1997), 85–94.
81. [81] Kalaria, R.N., Harik, S.I., Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J Neurochem 53 (1989), 1083–1088.
82. [82] Horwood, N., Davies, D.C., Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease. Virchows Arch 425 (1994), 69–72.
83. [83] Winkler, E.A., Nishida, Y., Sagare, A.P., Rege, S.V., Bell, R.D., Perlmutter, D., et al. GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 18 (2015), 521–530.
84. [84] Bien-Ly, N., Boswell, C.A., Jeet, S., Beach, T.G., Hoyte, K., Luk, W., et al. Lack of widespread BBB disruption in Alzheimer's disease models: focus on therapeutic antibodies. Neuron 88 (2015), 289–297.
85. [85] Ohayon, M.M., Lemoine, P., Arnaud-Briant, V., Dreyfus, M., Prevalence and consequences of sleep disorders in a shift worker population. J Psychosom Res 53 (2002), 577–583.
86. [86] Cho, K., Chronic 'jet lag' produces temporal lobe atrophy and spatial cognitive deficits. Nat Neurosci 4 (2001), 567–568.
87. [87] Marquie, J.C., Tucker, P., Folkard, S., Gentil, C., Ansiau, D., Chronic effects of shift work on cognition: findings from the VISAT longitudinal study. Occup Environ Med 72 (2015), 258–264.
88. [88] Naylor, E., Bergmann, B.M., Krauski, K., Zee, P.C., Takahashi, J.S., Vitaterna, M.H., et al. The circadian clock mutation alters sleep homeostasis in the mouse. J Neurosci Off J Soc Neurosci 20 (2000), 8138–8143.
89. [89] Kondratova, A.A., Dubrovsky, Y.V., Antoch, M.P., Kondratov, R.V., Circadian clock proteins control adaptation to novel environment and memory formation. Aging 2 (2010), 285–297.
90. [90] Musiek, E.S., Lim, M.M., Yang, G., Bauer, A.Q., Qi, L., Lee, Y., et al. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J Clin Invest 123 (2013), 5389–5400.
91. [91] Bouchard-Cannon, P., Mendoza-Viveros, L., Yuen, A., Kaern, M., Cheng, H.Y., The circadian molecular clock regulates adult hippocampal neurogenesis by controlling the timing of cell-cycle entry and exit. Cell Rep 5 (2013), 961–973.
92. [92] Riemersma-van der Lek, R.F., Swaab, D.F., Twisk, J., Hol, E.M., Hoogendijk, W.J., Van Someren, E.J., Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA 299 (2008), 2642–2655.
93. [93] Fagan, A.M., Mintun, M.A., Mach, R.H., Lee, S.Y., Dence, C.S., Shah, A.R., et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59 (2006), 512–519.
94. [94] Saper, CB, Scammell, TE, Lu, J, Hypothalamic regulation of sleep and circadian rhythms. Nature 437 (2005), 1257–1263.
95. [95] Sprecher, K.E., Bendlin, B.B., Racine, A.M., Okonkwo, O.C., Christian, B.T., Koscik, R.L., et al. Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults. Neurobiol Aging 36 (2015), 2568–2576.
96. Spira, A.P., Gamaldo, A.A., An, Y., Wu, M.N., Simonsick, E.M., Bilgel, M., et al. Self-reported sleep and beta-amyloid deposition in community-dwelling older adults. JAMA Neurol 70 (2013), 1537–1543.
97. [97] Ju, Y.E., McLeland, J.S., Toedebusch, C.D., Xiong, C., Fagan, A.M., Duntley, S.P., et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol 70 (2013), 587–593.
98. [98] Zhou, J.N., Hofman, M.A., Swaab, D.F., VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol aging 16 (1995), 571–576.
99. [99] Stopa, E.G., Volicer, L., Kuo-Leblanc, V., Harper, D., Lathi, D., Tate, B., et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J Neuropathol Exp Neurol 58 (1999), 29–39.
100. [100] Baloyannis, S.J., Mavroudis, I., Mitilineos, D., Baloyannis, I.S., Costa, V.G., The hypothalamus in Alzheimer's disease: a Golgi and electron microscope study. Am J Alzheimers Dis Other Demen 30 (2015), 478–487.
101. [101] Wang, J.L., Lim, A.S., Chiang, W.Y., Hsieh, W.H., Lo, M.T., Schneider, J.A., et al. Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans. Ann Neurol 78 (2015), 317–322.
102. [102] Braak, H., Del Tredici, K., The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 121 (2011), 171–181.
103. [103] Braak, H., Thal, D.R., Ghebremedhin, E., Del Tredici, K., Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70 (2011), 960–969.
104. [104] Platt, B., Drever, B., Koss, D., Stoppelkamp, S., Jyoti, A., Plano, A., et al. Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1. PloS One, 6, 2011 e27068.
105. [105] Wisor, J.P., Edgar, D.M., Yesavage, J., Ryan, H.S., McCormick, C.M., Lapustea, N., et al. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission. Neuroscience 131 (2005), 375–385.
106. [106] Song, H., Moon, M., Choe, H.K., Han, D.H., Jang, C., Kim, A., et al. Abeta-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer's disease. Mol Neurodegener, 10, 2015, 13.
107. [107] Blake, M.R., Holbrook, S.D., Kotwica-Rolinska, J., Chow, E.S., Kretzschmar, D., Giebultowicz, J.M., Manipulations of amyloid precursor protein cleavage disrupt the circadian clock in aging Drosophila. Neurobiol Dis 77 (2015), 117–126.
108. [108] Ford, E.S., Cunningham, T.J., Croft, J.B., Trends in self-reported sleep duration among us adults from 1985 to 2012. Sleep 38 (2015), 829–832.
109. [109] Alzheimer's, A., 2015 Alzheimer's disease facts and figures. Alzheimer's Dement J Alzheimer's Assoc 11 (2015), 332–384.
110. [110] Borbely, A.A., A two process model of sleep regulation. Hum Neurobiol 1 (1982), 195–204.
111. [111] Iliff, J.J., Lee, H., Yu, M., Feng, T., Logan, J., Nedergaard, M., et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest 123 (2013), 1299–1309.